Invention Description
Irritable bowel syndrome (IBS) is a prevalent and multifactorial gastrointestinal disorder that affects 10-15% of the US population. Because the pathophysiology of IBS remains poorly understood, current diagnostic tools and treatments are limited, with diagnosis often relying on symptom-based assessments and exclusion of other conditions. Increasing evidence links IBS, particularly diarrhea-predominant IBS, to distinct alterations in the gut microbiome. However, existing microbiome analysis techniques are expensive, time-intensive, and technically demanding, limiting their practicality in routine clinical settings. There remains a strong need for a rapid, reliable, and affordable method to identify microbiome signatures associated with IBS.
Researchers at Arizona State University have created a rapid method using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) to characterize the gut microbiome from fecal samples associated with IBS. The utilization of this MS-based technique to analyze spectral fingerprints from fecal samples enables it to characterize fecal samples from diarrhea-predominant IBS patients in comparison to those from healthy individuals. This approach offers potential as a fast, reproducible, and scalable screening tool, providing a practical alternative to complex sequencing methods for clinical diagnostics.
A MALDI-TOF MS-based approach enables rapid, reproducible, high-quality, and cost-effective characterization of the gut microbiome associated with IBS.
Potential Applications
- Clinical diagnostics for IBS screening and monitoring
- Development of non-invasive tests for gastrointestinal diseases
- Research tool for gut microbiome studies in health and disease
- Potential integration with machine learning for enhanced microbiome classification
- Pharmaceutical and biotech sectors targeting microbiome-related therapies
Benefits and Advantages
- Rapid and reproducible fecal sample characterization
- Cost-effective analysis compared to traditional methods
- Rapid characterization and comparison of fecal samples from IBS-D patients and healthy controls
- Yields reproducible spectra that are distinct across different patient samples
- Non-invasive sample collection through fecal analysis
- Consistent results confirmed by jackknife analysis and replicates
For more information about this opportunity, please see